BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for RJ Hazen

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.EBI
Glaxosmithkline
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.EBI
Glaxosmithkline
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor.EBI
Shionogi
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.EBI
Glaxosmithkline
Synergistic combination of immunologic inhibitors for the treatment of cancerBDB
The University of Chicago
BTK InhibitorsBDB
Merck Sharp & Dohme
Non-nucleoside reverse transcriptase inhibitorsBDB
Merck Sharp & Dohme
Androgen receptor antagonistsBDB
University of California
Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolinesBDB
Bayer Intellectual Property
Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.BDB
Eli Lilly